Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to -$176000.0.

  • Arcadia Biosciences' Change in Receivables fell 25855.86% to -$176000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $558000.0, marking a year-over-year increase of 941.18%. This contributed to the annual value of $762000.0 for FY2024, which is 51413.04% up from last year.
  • Per Arcadia Biosciences' latest filing, its Change in Receivables stood at -$176000.0 for Q3 2025, which was down 25855.86% from $224000.0 recorded in Q2 2025.
  • Arcadia Biosciences' Change in Receivables' 5-year high stood at $1.4 million during Q1 2022, with a 5-year trough of -$1.1 million in Q4 2022.
  • Moreover, its 5-year median value for Change in Receivables was $65000.0 (2023), whereas its average is $14052.6.
  • Per our database at Business Quant, Arcadia Biosciences' Change in Receivables plummeted by 1598571.43% in 2022 and then soared by 135714.29% in 2024.
  • Over the past 5 years, Arcadia Biosciences' Change in Receivables (Quarter) stood at -$7000.0 in 2021, then tumbled by 15985.71% to -$1.1 million in 2022, then skyrocketed by 105.77% to $65000.0 in 2023, then soared by 387.69% to $317000.0 in 2024, then plummeted by 155.52% to -$176000.0 in 2025.
  • Its last three reported values are -$176000.0 in Q3 2025, $224000.0 for Q2 2025, and $193000.0 during Q1 2025.